# Annurca Apple By-Products at Different Ripening Stages Inhibit AGE Formation and Protect Against AGE-Induced Cytotoxicity Through Antioxidant Activity

**Authors:** Maria Liccardo, Pasquale Perrone, Shana Perrella, Ivana Sirangelo, Stefania D’Angelo, Clara Iannuzzi

PMC · DOI: 10.3390/antiox15020200 · Antioxidants · 2026-02-03

## TL;DR

Annurca apple by-products at different ripening stages reduce harmful AGE formation and protect cells from AGE-related damage through antioxidant activity.

## Contribution

This study reveals the novel ability of Annurca apple by-products to inhibit AGE formation and cytotoxicity, with ripening enhancing their bioactive potential.

## Key findings

- Annurca apple by-products inhibit protein glycation and reduce AGE formation.
- Extracts protect endothelial cells from AGE-induced cytotoxicity by lowering ROS and inhibiting MAPK and caspase-3.
- Ripening increases bioactive compound concentration and cellular protection effectiveness.

## Abstract

Annurca apple extract is gaining growing attention for its beneficial properties, particularly its outstanding antioxidant activity. Using a combination of biophysical, cell, and molecular biology techniques, this study investigates the sustainable valorization of Annurca apple by-products at different ripening stages and their role in the formation of advanced glycation end-products (AGEs), as well as in protection against AGE-related cytotoxicity. AGEs are a class of compounds formed by non-enzymatic reactions between reducing sugars and proteins, lipids, or nucleic acids. They can be produced endogenously or ingested through dietary sources and tobacco smoke. AGEs accumulate in nearly all mammalian tissues and are linked to various health issues, such as diabetes and its related complications, cardiovascular disease, and neurodegenerative disorders. Our data show that Annurca apple by-products at different ripening stages differentially counteract AGEs’ formation by inhibiting protein glycation and protect against AGE-induced cytotoxicity in endothelial cells. In particular, the extracts reduce AGE-induced reactive oxygen species (ROS) production, thereby inhibiting MAPK signaling pathways and caspase-3 activation. Moreover, ripening significantly enhances the concentration of bioactive compounds and the extent of cellular protection. This study highlights new beneficial properties of Annurca apple extracts and suggests that adopting nutritional interventions may support health and potentially reduce the risk of complications associated with AGE accumulation.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CCL14 (C-C motif chemokine ligand 14) [NCBI Gene 6358] {aka CC-1, CC-3, CKB1, HCC-1, HCC-1(1-74), HCC-1/HCC-3}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}, MAPK [NCBI Gene 103456346], RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}
- **Diseases:** retinopathy (MESH:D058437), diabetic vascular complications (MESH:D003925), cancer (MESH:D009369), diabetes (MESH:D003920), renal failure (MESH:D051437), arteriosclerosis (MESH:D001161), hyperglycemia (MESH:D006943), peripheral vascular disease (MESH:D016491), inflammation (MESH:D007249), injury to (MESH:D014947), diseases (MESH:D004194), metabolic and degenerative disorders (MESH:D019636), mitochondrial dysfunction (MESH:D028361), neuropathy (MESH:D009422), nephropathy (MESH:D007674), AGE (OMIM:613784), ischemic heart disease (MESH:D017202), infections (MESH:D007239), cardiovascular disease (MESH:D002318), Cytotoxicity (MESH:D064420), cerebrovascular disease (MESH:D002561), vascular damage (MESH:D057772)
- **Chemicals:** HCl (MESH:D006851), ascorbic acid (MESH:D001205), SDS (MESH:D012967), Ins (MESH:D007328), hydroxytyrosol (MESH:C005975), NO (MESH:D009569), water (MESH:D014867), AGEs (MESH:D017127), Tyrosine (MESH:D014443), Ursolic acid (MESH:C005466), CAE (MESH:D002392), 2',7'-dichlorofluorescin diacetate (MESH:C029569), phenolic acids (MESH:C017616), quercetin (MESH:D011794), dihydrochalcones (MESH:C015812), flavonols (MESH:D044948), wax (MESH:D014885), Trolox (MESH:C010643), methanol (MESH:D000432), Trypan Blue (MESH:D014343), phosphate (MESH:D010710), sugar (MESH:D000073893), PVDF (MESH:C024865), PBS (MESH:D007854), ROS (MESH:D017382), flavonoid (MESH:D005419), glucose (MESH:D005947), chlorogenic acid (MESH:D002726), D-ribose (MESH:D012266), pentacyclic triterpenoids (MESH:D053978), Polyphenol (MESH:D059808), MG (MESH:D011765), Na2CO3 (MESH:C005686), lipid (MESH:D008055), ABTS (MESH:C002502), MTT (MESH:C070243), procyanidins (MESH:D044945), phloretin (MESH:D010693), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MESH:C022616), Annurca apple extracts (-), H2O2 (MESH:D006861), DCF (MESH:D015649)
- **Species:** Malus pumila (paradise apple, species) [taxon 283210], Nicotiana tabacum (American tobacco, species) [taxon 4097], Mus musculus (house mouse, species) [taxon 10090], Malus domestica (apple, species) [taxon 3750], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C with 0
- **Cell lines:** EA.HY926 — Homo sapiens (Human), Hybrid cell line (CVCL_3901), CRL-2922 — Homo sapiens (Human), Transformed cell line (CVCL_9L58)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937829/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937829/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937829/full.md

---
Source: https://tomesphere.com/paper/PMC12937829